Cardioprotection From Ischemia/Reperfusion Injury

Twenty-five years of preconditioning: are we ready for ischaemia? From coronary occlusion to systems biology and back

(2011) D. Garcia-Dorado et al.   CARDIOVASCULAR RESEARCH

New Horizons in Cardioprotection

(2011) Lisa Schwartz Longacre et al.   CIRCULATION

Biogenesis and Regulation of Cardiovascular MicroRNAs

(2011) Johann Bauersachs et al.   CIRCULATION RESEARCH

microRNAs in hypertrophy and heart failure

(2011) Michael V G Latronico et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction

(2011) Samer S. Najjar   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

MicroRNAs: New Players in Cardiac Injury and Protection

(2011) R. C. Kukreja et al.   MOLECULAR PHARMACOLOGY

The therapeutic potential of ischemic conditioning: an update

(2011) Derek J. Hausenloy et al.   Nature Reviews Cardiology

Controlled Delivery Systems: From Pharmaceuticals to Cells and Genes

(2011) Elizabeth Rosado Balmayor et al.   PHARMACEUTICAL RESEARCH

Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4

(2010) Y. Cheng et al.   CARDIOVASCULAR RESEARCH

Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

(2010) M. Ovize et al.   CARDIOVASCULAR RESEARCH

Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction

(2010) Masanori Obana et al.   CIRCULATION

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

(2010) et al.   CIRCULATION

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

(2010) Takuya Ozawa et al.   CIRCULATION JOURNAL

Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After ST-Elevated Acute Myocardial Infarction (EPOC-AMI)

(2010) Norimasa Taniguchi et al.   CIRCULATION JOURNAL

Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2010) Ilka Ott et al.   Circulation-Cardiovascular Interventions

Early outgrowth EPCs generation is reduced in patients with Buerger’s disease

(2010) Yoshio Katsuki et al.   Clinical Research in Cardiology

A single dose of erythropoietin in ST-elevation myocardial infarction

(2010) A. A. Voors et al.   EUROPEAN HEART JOURNAL

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

(2010) Hans Erik Bøtker et al.   LANCET

Thrombocytosis in EPO-Treated Dialysis Patients May Be Mediated by EPO Rather Than Iron Deficiency

(2009) Nosratola D. Vaziri   AMERICAN JOURNAL OF KIDNEY DISEASES

Ischemic postconditioning: experimental models and protocol algorithms

(2009) Andreas Skyschally et al.   BASIC RESEARCH IN CARDIOLOGY

A Novel Role of MicroRNA in Late Preconditioning

(2009) Chang Yin et al.   CIRCULATION RESEARCH

Prolonged Targeting of Ischemic/Reperfused Myocardium by Liposomal Adenosine Augments Cardioprotection in Rats

(2009) Hiroyuki Takahama et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy

(2008) Tetsuji Miura et al.   BASIC RESEARCH IN CARDIOLOGY

Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

(2008)   CIRCULATION

Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction

(2008) Christophe Piot et al.   NEW ENGLAND JOURNAL OF MEDICINE